macular degeneration

now browsing by tag

 
 

NEW Viteyes 2 SOFTGELS

We are proud of our claim to be the most cost-effective supplement for eye health and with the launch of our NEW softgels, we are able to offer you, our stockists an even LOWER price and RRP.

NEW Viteyes 2 softgels at an even LOWER price.

Read the rest of this page »

It’s Macular Week 2016 – top tips for eye health!

Who are The Macular Society?

Running from the 27th June to the 3rd of July, this year’s Macular Week organised by The Macular Society aims to raise awareness of an eye condition relating to the macula – an important but very small area for seeing at the back of the eye.This condition known as macular degeneration affects 600,000 people in the UK, many of whom rely on The Macular Society for support and advice through their large print, audio or online articles and newsletters, just email help@macularsociety.org or ring their telephone helpline (0300 3030 111). They also offer confidential telephone counselling sessions and nationwide support groups.

Read the rest of this page »

Viteyes visits Ophthalmologists and GP’s this week

This week, we have headed up the motorway to the ICC, Birmingham for the The Royal College of Ophthalmologists Annual Congress 2014. Every year, we hire a stand and take Viteyes brochures, samples and pens to give out to the delegates as we tell them about Viteyes – our nutritional supplement for eye health.

Viteyes for macular degeneration are attending The Royal College of Ophthalmologists Annual Congress 2014   RCO1 Viteyes for macular degeneration are attending The Royal College of Ophthalmologists Annual Congress 2014

We emphasise the strong research base behind Viteyes – as this is of high importance to prescribers such as ophthalmologists and GP’s. Evidence based prescribing ensures that patients receive the treatments that give the best results.

Read the rest of this page »

Viteyes is sponsoring the Gift of Sight charity carol concert

Gift of Sight is the charity set up to raise funds for the pioneering eye research at Southampton Eye Unit lead by Professor Andrew Lotery.  He specialises in macular degeneration and his team are at the forefront of new technologies to help develop new treatments in the future. Other areas of research are glaucoma, inherited retinal diseases such as retinitis pigmentosa and childhood conditions such as nystagmus.

During December Winchester holds a Christmas market and the town centre looks truly magical . A fundraising carol concert organised by Gift of Sight in Winchester College Chapel is dimly lit and we sponsor the purchase of pen torches with our logo on for everyone to use to read the hymn sheets. This gives an insight into how debilitating macular degeneration can be to those of us with full vision. This year’s concert on the 16th December  is sold out already.

Gift of Sight Carol Concert sponsored by Viteyes

Read the rest of this page »

Viteyes 2 is launched!


Viteyes 2 is the only eye vitamin available in the UK to match the recommended doses in the updated National Eye Institute research exactly. This makes it the clear first choice for maintaining eye health.

We have been working closely alongside Vitamin Health USA, the parent company of Viteyes to ensure a seamless yet quality controlled transition.

We have updated our Viteyes labels with bolder colour contrasts as well as our product literature, such as leaflets and brochures.

Read the rest of this page »

AREDS2 results are out

The long anticipated Age Related Eye Disease part 2 (AREDS 2) results were announced at ARVO (Association for Research in Vision and Ophthalmology) in Seattle on May 5th. This complex study began in 2006 and included 4203 participants and 82 clinics through the United States. It was designed to find out the best combination of vitamins, minerals and carotenoids to delay the progression of Age-related Macular Degeneration (AMD), currently the leading cause of sight loss in the developed world.

logo

Read the rest of this page »